|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Pharmacology
:
Antihypertensives
CCB and ACE inhibitors reduce diabetes risk in Hispanic patients
The combination of drugs traditionally used to control blood pressure might not be ideal for Hispanic patients, University of Florida researchers warn.
Jun 8, 2006, 16:39
Latest Research
:
Pharmacology
:
Antihypertensives
ACE inhibitors implicated in birth defects
The Food and Drug Administration is examining study data from Vanderbilt University Medical Center researchers, published this week in the New England Journal of Medicine, to determine if new warnings should be placed on common blood pressure medications indicating an increased risk of birth defects for babies whose mothers take these medications during the first trimester of pregnancy.
Jun 8, 2006, 16:37
Latest Research
:
Pharmacology
:
Antihypertensives
Latest Data on Nebivolol, the Investigational Beta-Blocker Compound
Mylan Laboratories Inc.,announced today that the results of new data on nebivolol,an investigational compound currently under review by the Food and Drug Administration for the treatment of hypertension,were presented at the 20th Annual Scientific Meeting of The American Society of Hypertension (ASH) held in San Francisco.
May 19, 2005, 13:07
Latest Research
:
Pharmacology
:
Antihypertensives
Metoprolol Shows Promise in Pediatric Hypertension
AstraZeneca announced new data for beta-blocker TOPROL-XL� (metoprolol succinate) extended-release tablets in treating hypertension in pediatric patients. The data was presented today in a press briefing at the 20th annual scientific meeting of the American Society of Hypertension (ASH) in San Francisco.
May 17, 2005, 08:35
Latest Research
:
Pharmacology
:
Antihypertensives
:
Thiazides
Trends in the Prescribing of Thiazides for Hypertension
Hypertension is common in affluent societies and a major risk factor for heart disease. In Canada, hypertension is the leading primary diagnosis for patient visits to physicians' offices. Beyond recommending lifestyle changes such as losing weight, quitting smoking, and lowering salt and alcohol intake, prescription drugs are indicated in many patients. As a consequence, antihypertensive drugs are the leading category of prescription drugs in Canada, accounting for 20% of prescription drug sales.
Apr 26, 2005, 22:26
|
